Lexicon Pharmaceuticals Provides Regulatory Update on Sotagliflozin in Heart Failure

NEXT STORY
Emergency Medical Supplies Market to reach US $440.11 billion by 2028 – Global Insights on Key Trends, COVID-19 Impact Analysis, Growth Opportunities, Expansion Plans and Future Prospect: Adroit Market Research
PREV STORY
Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives FDA Fast Track Designation
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Autolus Therapeutics presents compelling AUTO1 data from ALLCAR Phase 1 study in Adult Acute Lymphoblastic Leukemia (ALL) during the 62nd ASH Annual Meeting

author_avatar
NASDAQ Market News

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in the first nine months – outlook for 2021 raised

author_avatar
NASDAQ Market News

FDA grants Breakthrough Therapy Designation for Roche’s Tecentriq in combination with Avastin as first-line treatment for advanced or metastatic hepatocellular carcinoma (HCC)

Basel, 18 July 2018 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that ...

author_avatar
NASDAQ Market News